Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	6.22e-08	38	190	7	GO:0000146
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10 NAIP RUVBL2 HSPA4 DDX39B HSPA9 ACSL6 DNAH3 DHX40 DDX52 SMCHD1 HELQ DMC1 MSH6 ATP2A2	4.34e-07	614	190	21	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10 DNAH3	1.74e-05	118	190	8	GO:0003774
GeneOntologyMolecularFunction	transforming growth factor beta binding	CD109 NRROS ITGAV THBS1	1.01e-04	26	190	4	GO:0050431
GeneOntologyMolecularFunction	calcium ion binding	MYL6 CETN1 MATN1 FKBP9 ADGRV1 C2CD5 FBN2 CALU FAT3 NUCB1 APCS CBL MYOF THBS1 CAMKK2 SLC25A12 PITPNM3 NINL ATP2A2	1.01e-04	749	190	19	GO:0005509
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH4 MYH8 NAIP RUVBL2 DDX39B HSPA9 DNAH3 DHX40 DDX52 SMCHD1 HELQ DMC1 ATP2A2	3.23e-04	441	190	13	GO:0016887
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4 MYH6 MYH8 MYL6	1.85e-07	15	192	5	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYH6 MYH8 MYL6	5.15e-07	18	192	5	GO:0033275
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6	1.71e-07	28	191	6	GO:0016460
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4 MYH6 MYH8	2.43e-07	16	191	5	GO:0005859
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	1.09e-06	59	191	7	GO:0016459
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH6 MYH8	2.77e-06	25	191	5	GO:0032982
GeneOntologyCellularComponent	U4 snRNP	DDX39B SNRPB SNRPN	2.01e-04	13	191	3	GO:0005687
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH8	2.86e-07	15	190	5	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH8	2.86e-07	15	190	5	IPR004009
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH6 MYH8	7.95e-07	18	190	5	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH6 MYH8	7.95e-07	18	190	5	IPR002928
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH6 MYH8	1.07e-06	19	190	5	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH6 MYH8	1.07e-06	19	190	5	4.10.270.10
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10	2.16e-06	38	190	6	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10	2.16e-06	38	190	6	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10	2.16e-06	38	190	6	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10	2.16e-06	38	190	6	SM00242
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 UBE3C	7.75e-06	71	190	7	PF00612
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 UBE3C	1.86e-05	81	190	7	SM00015
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 UBE3C	3.70e-05	90	190	7	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 UBE3C	4.57e-05	93	190	7	PS50096
Domain	-	ADGRV1 COL19A1 FAT3 APCS LAMA4 LGALS4 THBS1	5.24e-05	95	190	7	2.60.120.200
Domain	P-loop_NTPase	MYH1 MYH2 MYH4 MYH6 MYH8 THNSL1 MYO10 NAIP RUVBL2 RAB3C MAGI2 DDX39B DNAH3 DHX40 DDX52 DTYMK HELQ DMC1 MSH6 GTPBP2 HYDIN TJP3	5.39e-05	848	190	22	IPR027417
Domain	snRNP-assoc_SmB/SmN	SNRPB SNRPN	1.03e-04	2	190	2	IPR017131
Domain	MARK/par1	MARK3 MARK4	6.09e-04	4	190	2	IPR033624
Domain	EF-hand_1	MYL6 CETN1 FKBP9 CALU NUCB1 SLC25A12 NINL	9.45e-04	152	190	7	PF00036
Domain	AWS	NSD3 NSD2	1.01e-03	5	190	2	SM00570
Domain	-	ALDH1L1 AASDH	1.01e-03	5	190	2	1.10.1200.10
Domain	Hexokinase_2	HK1 HKDC1	1.01e-03	5	190	2	PF03727
Domain	AWS	NSD3 NSD2	1.01e-03	5	190	2	PS51215
Domain	KA1	MARK3 MARK4	1.01e-03	5	190	2	PF02149
Domain	AWS_dom	NSD3 NSD2	1.01e-03	5	190	2	IPR006560
Domain	Hexokinase_BS	HK1 HKDC1	1.01e-03	5	190	2	IPR019807
Domain	KA1_dom	MARK3 MARK4	1.01e-03	5	190	2	IPR001772
Domain	Hexokinase_C	HK1 HKDC1	1.01e-03	5	190	2	IPR022673
Domain	Hexokinase_N	HK1 HKDC1	1.01e-03	5	190	2	IPR022672
Domain	Hexokinase_1	HK1 HKDC1	1.01e-03	5	190	2	PF00349
Domain	PP-binding	ALDH1L1 AASDH	1.01e-03	5	190	2	PF00550
Domain	ACP_DOMAIN	ALDH1L1 AASDH	1.01e-03	5	190	2	PS50075
Domain	KA1	MARK3 MARK4	1.01e-03	5	190	2	PS50032
Domain	-	MARK3 MARK4	1.01e-03	5	190	2	3.30.310.80
Domain	HEXOKINASE_2	HK1 HKDC1	1.01e-03	5	190	2	PS51748
Domain	HEXOKINASE_1	HK1 HKDC1	1.01e-03	5	190	2	PS00378
Domain	PWWP	NSD3 NSD2 MSH6	1.04e-03	20	190	3	SM00293
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	HK1 MYL6 SSR1 SSRP1 RUVBL2 RCC2 NSD3 CIRBP FEN1 DDX39B MED12 NSD2 HNRNPA3 FNBP4 CCDC61 MSH6 TBC1D10B SF3B3 SLC25A12 MKX ELAVL3 TAF15 SNRPB SRRM2 CATSPERG ATP2A2 ZNF292	1.08e-10	1082	196	27	38697112
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4 MYH6 MYH8	1.12e-10	7	196	5	16819597
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HK1 MYL6 SSR1 EDC4 SSRP1 ANKHD1 RUVBL2 RCC2 UCHL1 PRMT5 FEN1 HSPA4 DDX39B HSPA9 NSD2 CALU ACAD9 DDX52 SMCHD1 HNRNPA3 GRM1 LAP3 MSH6 PPP2R1A SF3B3 PDCD11 SLC7A5 UBE3C SNRPB SRRM2 ATP2A2	1.18e-10	1425	196	31	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH6 HK1 MYL6 MARK3 FKBP9 NCAM2 ALDH1L1 EDC4 GFAP MAGI2 UCHL1 PRMT5 HSPA4 DDX39B HSPA9 ACSL6 DPYSL3 RAP1GDS1 HNRNPA3 ARFGEF2 GRM1 EPN2 PPP2R1A DZANK1 SF3B3 SLC25A12 SIPA1L1 ELAVL3 TAF15 ATP2A2 SNRPN	1.30e-10	1431	196	31	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 MYH2 MYH4 MYH6 MYH8 HK1 ACADVL EML6 SSRP1 RAB3C SLC22A14 PDIA2 DDX39B HSPA9 NSD2 DDX52 SMCHD1 NUCB1 HNRNPA3 HKDC1 STK31 SF3B3 TBC1D31 SLC25A12 SLC7A5 TAF15 ZNF350 SNRPB ATP2A2 SNRPN ZNF292	1.57e-10	1442	196	31	35575683
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	MYL6 ACADVL PBK SSR1 SSRP1 ANKHD1 RUVBL2 RCC2 CIRBP PRMT5 NAF1 FEN1 HSPA4 DDX39B HSPA9 NAXE SMCHD1 HNRNPA3 FNBP4 MSH6 PPP2R1A SF3B3 SLC7A5 IAH1 EXOC2 SNRPB SRRM2 ATP2A2 SNRPN	1.95e-09	1415	196	29	28515276
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MYH2 HK1 MARK3 CD109 L2HGDH EDC4 SSRP1 RCC2 PRMT5 ACAA2 MMS19 HSPA4 CALU ACAD9 HNRNPA3 CTSA MSH6 MYOF PPP2R1A SF3B3 SIPA1L1 MKX PDCD11 SLC7A5 UBE3C EXOC2 SNRPB ATP2A2 EVI5L	2.89e-09	1440	196	29	30833792
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	HK1 SSR1 ANKHD1 RUVBL2 GFAP RAB3C UCHL1 KCNMA1 ACAA2 MMS19 HSPA4 HSPA9 CALU NUCB1 ARFGEF2 THBS1 SLC25A12 ATP2A2	4.07e-09	564	196	18	21565611
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4 MYH8	4.87e-09	5	196	4	3829126
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4 MYH8	4.87e-09	5	196	4	12919077
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4 MYH8	4.87e-09	5	196	4	6196357
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYL6 SSRP1 ANKHD1 RUVBL2 C2CD5 NSD3 FBN2 NAF1 MMS19 NSD2 POGK CALU DDX52 WWP1 FAT3 MSH6 TBC1D10B GTPBP2 SF3B3 SLC25A12 CCNB3 SIPA1L1 MARK4 SRRM2 EVI5L	4.95e-09	1116	196	25	31753913
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	HK1 MYL6 SSRP1 ANKHD1 RUVBL2 RCC2 CIRBP UCHL1 PRMT5 FEN1 MMS19 HSPA4 DDX39B HSPA9 NAXE DPYSL3 CALU HNRNPA3 LAP3 MSH6 PPP2R1A SF3B3 SNRPB SRRM2 ATP2A2	8.82e-09	1149	196	25	35446349
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SLC6A17 NAIP NCAM2 C2CD5 MAGI2 KCNMA1 DPYSL3 HNRNPA3 EPN2 CAMKK2 SIPA1L1 PITPNM3 SRRM2 ATP2A2	1.28e-08	347	196	14	17114649
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4 MYH8	1.45e-08	6	196	4	1728586
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4 MYH8	1.45e-08	6	196	4	10077619
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4 MYH8	1.45e-08	6	196	4	10588881
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	MYL6 SSRP1 ANKHD1 RUVBL2 GFAP PRMT5 FEN1 HSPA4 HNRNPA3 MSH6 PPP2R1A TBC1D10B PDCD11 TAF15 EXOC2 SRRM2 ATP2A2 SNRPN	2.89e-08	641	196	18	36057605
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4 MYH8	3.38e-08	7	196	4	35210422
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	HK1 MYL6 ACADVL RUVBL2 GFAP CIRBP UCHL1 FEN1 HSPA4 HSPA9 DNAH3 DPYSL3 CALU NUCB1 HNRNPA3 LAP3 MYOF SF3B3 SLC25A12 ATP2A2	3.44e-08	803	196	20	36517590
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	HK1 EDC4 ANKHD1 RCC2 PRMT5 HSPA4 MED12 HSPA9 NSD2 DDX52 SMCHD1 HNRNPA3 MSH6 PPP2R1A PDCD11 TAF15 SRRM2 ATP2A2	3.82e-08	653	196	18	22586326
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	MYL6 MARK3 EDC4 RUVBL2 RCC2 CIRBP PRMT5 FEN1 HSPA4 HSPA9 DHX40 SMCHD1 HNRNPA3 CTSA MSH6 DZANK1 TBC1D10B SF3B3 TAF15 SRRM2	3.88e-08	809	196	20	32129710
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HK1 MYL6 FKBP9 EDC4 SSRP1 RUVBL2 RCC2 PRMT5 NAF1 FEN1 ACAA2 MMS19 HSPA4 DDX39B HSPA9 DPYSL3 RAP1GDS1 CALU NUCB1 ARFGEF2 CTSA LAP3 STAMBP MSH6 PPP2R1A UBE3C SNRPB	5.76e-08	1455	196	27	22863883
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4 MYH6	6.73e-08	8	196	4	14667415
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH4 MYH6 MYH8	6.73e-08	8	196	4	3864153
Pubmed	RNA binding proteins co-localize with small tau inclusions in tauopathy.	HK1 GFAP RAB3C UCHL1 ACAA2 HSPA4 DPYSL3 RAP1GDS1 PPP2R1A SLC25A12 TAF15 ATP2A2	8.42e-08	283	196	12	30068389
Pubmed	Proteomic analysis of the NOS2 interactome in human airway epithelial cells.	RUVBL2 HSPA4 HSPA9 CALU HKDC1 PPP2R1A SLC7A5 SNRPB ATP2A2	9.77e-08	138	196	9	23438482
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	HK1 ACADVL FKBP9 SSR1 ITGAV UCHL1 FEN1 ACAA2 HSPA4 HSPA9 NAXE CALU NUCB1 HNRNPA3 LAMA4 LAP3 MYOF PPP2R1A SLC25A12 ATP2A2	1.02e-07	859	196	20	31536960
Pubmed	The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.	MYL6 SSRP1 RUVBL2 RCC2 FEN1 HSPA4 HSPA9 HNRNPA3 MSH6 PPP2R1A SLC25A12 TAF15 SRRM2	1.12e-07	350	196	13	26549023
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	MYL6 MYO10 MARK3 CD109 SSR1 SSRP1 RCC2 PRMT5 FEN1 DDX39B HSPA9 DDX52 HNRNPA3 TBC1D10B SF3B3 PDCD11 SLC7A5 SNRPB SRRM2 ATP2A2 SNRPN	1.13e-07	949	196	21	36574265
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH2 MYH4 MYH6 MYH8	1.32e-07	22	196	5	24301466
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	L2HGDH RUVBL2 UCHL1 PRMT5 FEN1 MMS19 HSPA4 HSPA9 DPYSL3 RAP1GDS1 CALU ACAD9 DTYMK LAP3 STAMBP PPP2R1A SLC25A12 SLC7A5 ATP2A2 ZNF292	1.45e-07	878	196	20	37223481
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	MYL6 PBK SSR1 SSRP1 ANKHD1 RUVBL2 GFAP RCC2 CIRBP PRMT5 MMS19 HSPA4 DDX39B HSPA9 ACAD9 DHX40 DDX52 HNRNPA3 MSH6 PPP2R1A SF3B3 SLC25A12 SLC7A5 SNRPB ATP2A2	1.58e-07	1335	196	25	29229926
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	1.76e-07	3	196	3	26059207
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	RUVBL2 MMS19 MED12 HSPA9 AKAP6 CALU LGALS4 PPP2R1A ATP2A2 TJP3	1.80e-07	195	196	10	17110338
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 ACADVL SSR1 RUVBL2 MMS19 HSPA4 HSPA9 CALU PPP2R1A SLC25A12 UBE3C ATP2A2	1.83e-07	647	196	17	26618866
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	SSR1 PRMT5 MMS19 HSPA9 PPP2R1A SF3B3 SLC25A12 PDCD11 UBE3C ATP2A2	1.98e-07	197	196	10	31620119
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MYL6 MARK3 CD109 EDC4 SSRP1 RUVBL2 RCC2 NSD3 PRMT5 FEN1 DDX39B HSPA9 DDX52 SMCHD1 HNRNPA3 MSH6 MYOF PPP2R1A THBS1 SF3B3 SIPA1L1 PDCD11 SLC7A5 SNRPB	2.01e-07	1257	196	24	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HK1 MYL6 L2HGDH SSR1 SSRP1 RUVBL2 RCC2 PRMT5 MMS19 HSPA4 DDX39B MED12 HSPA9 HNRNPA3 MSH6 PPP2R1A SF3B3 SLC25A12 SLC7A5 TAF15 UBE3C SNRPB ATP2A2 SNRPN	2.01e-07	1257	196	24	37317656
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	MYL6 ACADVL CD109 FKBP9 SSR1 ITGAV MAGI2 SUMF1 ACAA2 HSPA9 ALOX15 CALU ACAD9 NUCB1 HNRNPA3 HKDC1 OAS2 CBL CTSA SF3B3 SLC25A12 FARS2 SNRPB CATSPERG ATP2A2 CSGALNACT1	2.04e-07	1451	196	26	30550785
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH4 MYL6 MMS19 SMCHD1 ARFGEF2 SALL4 MSH6 MYOF THBS1 ATP2A2	2.50e-07	202	196	10	33005030
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	HK1 ACADVL EDC4 RUVBL2 RCC2 UCHL1 PRMT5 HSPA9 SMCHD1 HNRNPA3 HKDC1 PPP2R1A SLC25A12 SLC7A5 SRRM2 ATP2A2 SNRPN	2.68e-07	665	196	17	30457570
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4 MYH8	3.13e-07	11	196	4	8136524
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4 FBN2	3.13e-07	11	196	4	38303699
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NR2C1 MYL6 EDC4 SSRP1 RUVBL2 LIN9 RCC2 CIRBP FEN1 HSPA4 MED12 HSPA9 CALU DTYMK SMCHD1 HNRNPA3 AASDH MSH6 QSER1 SRRM2 ATP2A2 ZNF292	3.25e-07	1103	196	22	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYO10 EDC4 ANKHD1 NSD3 PIK3C2B SUMF1 OSBPL5 MED12 WDR24 NSD2 WWP1 MYOM3 ARFGEF2 MYOF MARK4 NINL PDCD11 LRP5 SLC7A5 UBE3C EVI5L TJP3	3.35e-07	1105	196	22	35748872
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MYL6 CD109 FKBP9 L2HGDH SSR1 ANKHD1 ITGAV NSD3 MMS19 HSPA4 HSPA9 CALU ACAD9 SMCHD1 NUCB1 HNRNPA3 CTSA MYOF PPP2R1A PDCD11 IAH1 UBE3C SRRM2 ATP2A2	3.54e-07	1297	196	24	33545068
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	HK1 MYL6 PBK SSRP1 RUVBL2 FEN1 HSPA4 DDX39B HSPA9 DNAH3 DPYSL3 HNRNPA3 HKDC1 MSH6 PPP2R1A TBC1D10B SF3B3 LRP5 SNRPB	3.81e-07	847	196	19	35235311
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MYL6 MARK3 SSRP1 RUVBL2 RCC2 PRMT5 HSPA4 DDX39B MED12 HSPA9 CALU DDX52 WWP1 HNRNPA3 SIM2 MYOF PPP2R1A SF3B3 SIPA1L1 TAF15 SRRM2 ATP2A2 TJP3	6.69e-07	1247	196	23	27684187
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4 MYH8	6.72e-07	13	196	4	8404542
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	MYL6 EDC4 SSRP1 ANKHD1 RUVBL2 RCC2 CIRBP FEN1 DDX39B HSPA9 SMCHD1 HNRNPA3 THBS1 PDCD11 TAF15 SNRPB ATP2A2	6.76e-07	711	196	17	33022573
Pubmed	Evaluation of embryonic and perinatal myosin gene mutations and the etiology of congenital idiopathic clubfoot.	MYH1 MYH2 MYH8	7.02e-07	4	196	3	20357587
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH4 MYH8	7.02e-07	4	196	3	1985022
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	7.02e-07	4	196	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	7.02e-07	4	196	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	7.02e-07	4	196	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	7.02e-07	4	196	3	11023856
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	SSRP1 ANKHD1 PRMT5 FEN1 MMS19 HSPA4 DDX39B HSPA9 CALU DHX40 DDX52 HNRNPA3 PPP2R1A SF3B3 ELAVL3 SNRPB SRRM2	7.16e-07	714	196	17	28302793
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MIS18BP1 HK1 SSRP1 ANKHD1 RUVBL2 FEN1 ACAA2 MMS19 HSPA4 DDX39B MED12 HSPA9 DHX40 DDX52 SMCHD1 HNRNPA3 MSH6 PPP2R1A SF3B3 SLC25A12 PDCD11 EXOC2 SRRM2 ATP2A2	7.50e-07	1353	196	24	29467282
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	MARK3 SSR1 SSRP1 RCC2 NAF1 FEN1 HSPA9 DHX40 DDX52 HNRNPA3 SLC25A12 PDCD11 UBE3C SRRM2	7.83e-07	486	196	14	30940648
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MYL6 SSRP1 RUVBL2 CIRBP HSPA4 DDX39B HSPA9 CALU DHX40 DDX52 SMCHD1 HNRNPA3 LAP3 MSH6 SF3B3 PDCD11 TAF15 SRRM2 ATP2A2 SNRPN	9.34e-07	989	196	20	36424410
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH4 MYH8	9.37e-07	14	196	4	27184118
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH2 MYH4 MYH6	9.37e-07	14	196	4	24938781
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MYL6 MARK3 ADGRV1 GFAP MAGI2 ACSL6 DYNC2I2 GABBR2 DZANK1 TBC1D10B THBS1 SIPA1L1 MARK4	1.15e-06	430	196	13	32581705
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MARK3 SSR1 EDC4 SSRP1 ANKHD1 LIN9 RCC2 NSD3 CIRBP PRMT5 MED12 NSD2 ACAD9 DHX40 DDX52 EPN2 MSH6 MYOF ZBED6 SIPA1L1 PDCD11 SLC7A5 TAF15 EXOC2 ATP2A2	1.29e-06	1497	196	25	31527615
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CD109 FKBP9 PBK SSR1 ITGAV FBN2 PRMT5 SUMF1 NAXE NPR1 DPYSL3 CALU NUCB1 ARFGEF2 LAMA4 CTSA MYOF THBS1 LRP5 SLC7A5 ATP2A2 CSGALNACT1	1.33e-06	1201	196	22	35696571
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	HK1 SSR1 RUVBL2 CIRBP FEN1 DDX39B TRAPPC11 DDX52 SMCHD1 LAP3 PDCD11 UBE3C SNRPB SRRM2 CATSPERG ATP2A2	1.48e-06	670	196	16	22990118
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ACADVL EDC4 SSRP1 RUVBL2 RCC2 UCHL1 PRMT5 HSPA4 DDX39B HSPA9 DDX52 SMCHD1 HNRNPA3 PPP2R1A SF3B3 PDCD11 TAF15 SNRPB SRRM2 ATP2A2	1.59e-06	1024	196	20	24711643
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4 MYH6	1.69e-06	16	196	4	19922871
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	NR2C1 MYL6 ACADVL SSRP1 RUVBL2 PRMT5 BTK FEN1 HSPA4 DDX39B HSPA9 DDX52 SMCHD1 HNRNPA3 LAP3 MSH6 SF3B3 SLC25A12 PDCD11 TAF15 SNRPB SRRM2 ATP2A2	1.71e-06	1318	196	23	30463901
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	1.75e-06	5	196	3	30737693
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH2 MYH4 MYH8 ATP2A2	2.20e-06	17	196	4	16124007
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NR2C1 MYL6 SSRP1 RCC2 NSD3 FEN1 DDX39B NSD2 SMCHD1 HNRNPA3 FNBP4 SF3B3 PDCD11 TAF15 QSER1 SNRPB SRRM2 ATP2A2 SNRPN	2.21e-06	954	196	19	36373674
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH1 MYH2 MYH4 MYH8 MED12	2.66e-06	39	196	5	38690566
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	RCC2 CIRBP HSPA9 HNRNPA3 TAF15 SNRPB SRRM2 SNRPN	2.71e-06	153	196	8	28225217
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EDC4 SSRP1 RUVBL2 NSD3 DDX52 SMCHD1 HNRNPA3 PPP2R1A TBC1D10B PDCD11 EXOC2 SNRPN	2.78e-06	394	196	12	27248496
Pubmed	Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.	MYH1 MYH2 MYH4 GFAP	2.81e-06	18	196	4	25753484
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	MYL6 MYO10 RUVBL2 RCC2 CIRBP PRMT5 NAF1 HSPA4 DDX39B HSPA9 SMCHD1 UBE2C HNRNPA3 MSH6 PPP2R1A SF3B3 PDCD11 SNRPB SRRM2	2.86e-06	971	196	19	33306668
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	HK1 SSR1 SSRP1 RUVBL2 RCC2 FEN1 HSPA4 HSPA9 RAP1GDS1 CALU DTYMK HNRNPA3 CTSA LAP3 MSH6 MYOF PPP2R1A SF3B3 PDCD11 SLC7A5 SNRPB ATP2A2 MMUT	3.14e-06	1367	196	23	32687490
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EDC4 SSRP1 ANKHD1 RUVBL2 NSD3 MED12 DPYSL3 SMCHD1 FNBP4 CBL MSH6 PPP2R1A PDCD11 QSER1	3.24e-06	549	196	14	38280479
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	3.48e-06	6	196	3	20417199
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	3.48e-06	6	196	3	17559643
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	EDC4 SSRP1 RUVBL2 RCC2 HSPA4 DDX39B HSPA9 DDX52 HNRNPA3 PPP2R1A SF3B3 PDCD11 UBE3C ATP2A2 SNRPN	3.84e-06	638	196	15	33239621
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MYL6 SSRP1 RUVBL2 LIN9 RCC2 NSD3 DDX39B HSPA9 NSD2 DDX52 SMCHD1 HNRNPA3 FNBP4 PPP2R1A SF3B3 PDCD11 SLC7A5 TAF15 QSER1 SRRM2 ATP2A2 SNRPN	4.43e-06	1294	196	22	30804502
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	EDC4 RCC2 FBN2 ACAA2 HSPA9 DDX52 MSH6 SF3B3 EXOC2	4.66e-06	219	196	9	31353912
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	HK1 SSRP1 RCC2 C2CD5 MMS19 HSPA9 CALU ACAD9 CBL MSH6 SF3B3 SLC7A5 TAF15 UBE3C SRRM2	5.08e-06	653	196	15	33742100
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4	6.07e-06	7	196	3	29758057
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 ACADVL RCC2 MMS19 HSPA9 DPYSL3 CALU HNRNPA3 PPP2R1A SF3B3 TAF15 IAH1	6.70e-06	844	196	17	25963833
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	MYL6 SSRP1 CIRBP HSPA4 DDX39B HSPA9 DDX52 HNRNPA3 SF3B3 PDCD11 TAF15 SNRPB	6.74e-06	430	196	12	38172120
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MYL6 SSRP1 RUVBL2 NSD3 CIRBP FEN1 CALU DDX52 HNRNPA3 FNBP4 SF3B3 PDCD11 SLC7A5 TAF15 SRRM2 ATP2A2 SNRPN	7.01e-06	847	196	17	35850772
Pubmed	Proteomic analysis reveals Hrs ubiquitin-interacting motif-mediated ubiquitin signaling in multiple cellular processes.	GFAP OSBPL5 SF3B3 MARK4 ATP2A2	8.42e-06	49	196	5	19019082
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	MYL6 SSRP1 RCC2 PRMT5 HSPA4 DDX39B HSPA9 NSD2 HNRNPA3 MSH6 TAF15 SNRPB	8.69e-06	441	196	12	31239290
Pubmed	The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.	HK1 MYL6 MARK3 SSR1 SSRP1 DDX39B HSPA9 ACAD9 DDX52 HNRNPA3 TBC1D10B SF3B3 SLC7A5 ATP2A2	9.56e-06	604	196	14	37616343
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	9.67e-06	8	196	3	33667029
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4	9.67e-06	8	196	3	26993635
Pubmed	Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition.	RUVBL2 UCHL1 HSPA4 CALU NUCB1 HKDC1 ATP2A2 SNRPN	9.76e-06	182	196	8	36225252
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	HK1 SSR1 SSRP1 ANKHD1 RUVBL2 FEN1 ACAA2 DDX39B TRAPPC11 POGK DDX52 LAP3 MSH6 SLC25A12 PDCD11	1.24e-05	704	196	15	29955894
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYH6 HK1 MYL6 NAIP GFAP RAB3C HSPA9 ACSL6 DPYSL3 HNRNPA3 SLC25A12 SIPA1L1 ELAVL3 ATP2A2	1.30e-05	621	196	14	22794259
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	EDC4 RCC2 PRMT5 HSPA4 HSPA9 DPYSL3 HNRNPA3 MSH6 PPP2R1A SIPA1L1	1.33e-05	315	196	10	26777405
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH1 MYH2 MYH4	1.44e-05	9	196	3	31960486
Interaction	WDR76 interactions	EDC4 SSRP1 RCC2 FBN2 FEN1 ACAA2 HSPA9 DDX52 SMCHD1 HNRNPA3 MSH6 PPP2R1A SF3B3 EXOC2 SRRM2	3.99e-06	383	191	15	int:WDR76
Interaction	ACE2 interactions	MYL6 SSR1 SSRP1 ANKHD1 RUVBL2 GFAP TULP3 UCHL1 PRMT5 FEN1 HSPA4 DDX39B HNRNPA3 EPN2 MSH6 MYOF PPP2R1A TBC1D10B GTPBP2 PDCD11 SLC7A5 TAF15 EXOC2 SNRPB SRRM2 ATP2A2 SNRPN	5.99e-06	1106	191	27	int:ACE2
Interaction	KCTD13 interactions	MYH6 HK1 MYL6 MARK3 FKBP9 NCAM2 ALDH1L1 EDC4 GFAP MAGI2 UCHL1 PRMT5 HSPA4 DDX39B HSPA9 ACSL6 DPYSL3 RAP1GDS1 HNRNPA3 ARFGEF2 GRM1 EPN2 PPP2R1A DZANK1 SF3B3 SLC25A12 SIPA1L1 ELAVL3 TAF15 ATP2A2 SNRPN	7.58e-06	1394	191	31	int:KCTD13
Interaction	PTEN interactions	ACADVL PBK EDC4 SSRP1 RCC2 CIRBP MAGI2 FBN2 FEN1 HSPA4 MED12 NSD2 WWP1 SMCHD1 HNRNPA3 CBL STAMBP MSH6 MYOF SF3B3 TBC1D31 P2RY11 PDCD11 ATP2A2	8.17e-06	929	191	24	int:PTEN
Interaction	THOC6 interactions	SSRP1 MMS19 DDX39B PPP2R1A TAF15 SNRPB SRRM2	1.90e-05	87	191	7	int:THOC6
Interaction	LRRC31 interactions	MYH4 MYL6 MMS19 SMCHD1 ARFGEF2 SALL4 MSH6 MYOF THBS1 ATP2A2	2.70e-05	205	191	10	int:LRRC31
Interaction	ETV3 interactions	NR2C1 RCC2 NSD3 DDX52 SMCHD1 SF3B3 PDCD11 SRRM2	3.05e-05	128	191	8	int:ETV3
Interaction	MECP2 interactions	HK1 MYL6 SSR1 SSRP1 RUVBL2 RCC2 NSD3 CIRBP FEN1 DDX39B MED12 NSD2 HNRNPA3 FNBP4 CCDC61 MSH6 TBC1D10B SF3B3 SLC25A12 MKX PDCD11 ELAVL3 TAF15 SNRPB SRRM2 CATSPERG ATP2A2 ZNF292	3.28e-05	1287	191	28	int:MECP2
Interaction	AIRE interactions	SSRP1 RUVBL2 HSPA4 MSH6 SF3B3 SNRPB SRRM2	3.85e-05	97	191	7	int:AIRE
Interaction	IQCB1 interactions	HK1 RUVBL2 RAB3C UCHL1 ACAA2 MMS19 HSPA4 HSPA9 CALU NUCB1 ARFGEF2 THBS1 ATP2A2	5.50e-05	370	191	13	int:IQCB1
Interaction	UCN3 interactions	CD109 ADGRV1 FAT3 HKDC1	6.01e-05	23	191	4	int:UCN3
Interaction	BIRC3 interactions	HK1 MYL6 SSR1 EDC4 SSRP1 RUVBL2 RCC2 UCHL1 PRMT5 FEN1 HSPA4 DDX39B HSPA9 CALU ACAD9 DDX52 SMCHD1 HNRNPA3 LAP3 MSH6 PPP2R1A SF3B3 PDCD11 SLC7A5 UBE3C SNRPB SRRM2 ATP2A2	6.15e-05	1334	191	28	int:BIRC3
Interaction	ANKRD55 interactions	SSR1 PRMT5 MMS19 HSPA9 PPP2R1A SF3B3 SLC25A12 PDCD11 UBE3C ATP2A2	6.64e-05	228	191	10	int:ANKRD55
Interaction	NOS2 interactions	RUVBL2 HSPA4 HSPA9 CALU HKDC1 PPP2R1A SLC7A5 SNRPB ATP2A2	7.30e-05	186	191	9	int:NOS2
Interaction	HIF1A interactions	MYH1 MYH2 MYH4 MYH6 HK1 RUVBL2 UCHL1 MMS19 HSPA4 MED12 CBL MSH6 PPP2R1A UBE3C	8.44e-05	441	191	14	int:HIF1A
Interaction	ZFAND6 interactions	CIRBP NAXE HNRNPA3 PPP2R1A	8.46e-05	25	191	4	int:ZFAND6
Interaction	EFTUD2 interactions	MYL6 ACADVL PBK SSR1 SSRP1 ANKHD1 RUVBL2 RCC2 CIRBP PRMT5 NAF1 FEN1 HSPA4 DDX39B MED12 HSPA9 NAXE SMCHD1 HNRNPA3 FNBP4 MSH6 PPP2R1A SF3B3 TAF15 IAH1 EXOC2 SNRPB SRRM2 SNRPN	1.04e-04	1449	191	29	int:EFTUD2
Interaction	SCARB2 interactions	HK1 CD109 L2HGDH MYOF THBS1 SF3B3 PDCD11 TAF15 SNRPB	1.05e-04	195	191	9	int:SCARB2
Interaction	CDK3 interactions	MYH1 MYH2 MYH6 MYH8 OR2G6 HSPA4 NUCB1	1.08e-04	114	191	7	int:CDK3
Interaction	BAP1 interactions	HK1 MYL6 ALDH1L1 SSRP1 ANKHD1 RUVBL2 RCC2 CIRBP UCHL1 PRMT5 FEN1 MMS19 HSPA4 DDX39B HSPA9 NAXE DPYSL3 CALU WWP1 HNRNPA3 LAP3 MSH6 PPP2R1A SF3B3 SNRPB SRRM2 ATP2A2	1.20e-04	1314	191	27	int:BAP1
Cytoband	17p13.1	MYH1 MYH2 MYH4 MYH8 ACADVL	1.60e-04	118	196	5	17p13.1
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH6 MYH8	5.65e-08	15	133	5	1098
GeneFamily	PWWP domain containing	NSD3 NSD2 MSH6	5.41e-04	22	133	3	1147
GeneFamily	EF-hand domain containing	MYL6 CETN1 FKBP9 CALU NUCB1 SLC25A12 NINL	1.19e-03	219	133	7	863
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	ANKHD1 LIN9 RCC2 FEN1 KCNMA1 HSPA4 HSPA9 CALU DDX52 UBE2C ARFGEF2 CTSA MSH6 GTPBP2 MKX SLC7A5 QSER1 UBE3C SNRPB	2.07e-06	721	195	19	M10237
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8	1.31e-05	20	195	4	M1123
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8	1.61e-05	21	195	4	MM1102
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 SLC6A17 NCAM2 ADGRV1 FREM1 FBN2 COL19A1 FOLH1 FAT3 SALL4 GRM1 LOXHD1 HYDIN	1.92e-12	184	195	13	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 SLC6A17 NCAM2 ADGRV1 FREM1 FBN2 COL19A1 FOLH1 FAT3 SALL4 GRM1 LOXHD1 HYDIN	1.92e-12	184	195	13	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 SLC6A17 NCAM2 ADGRV1 FREM1 FBN2 COL19A1 FOLH1 FAT3 SALL4 GRM1 LOXHD1 HYDIN	1.92e-12	184	195	13	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 COL6A5 ADGRV1 RAB3C FREM1 FBN2 KCNMA1 FAT3 SIM2 FSHR MKX HYDIN	6.88e-12	160	195	12	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 COL6A5 ADGRV1 RAB3C FREM1 FBN2 KCNMA1 FAT3 SIM2 FSHR MKX HYDIN	6.88e-12	160	195	12	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALLC SLC6A17 COL6A5 FBN2 KCNK6 COL19A1 FAT3 LAMA4 HYDIN	2.92e-08	155	195	9	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH8 COL19A1 LAMA4 GRM1 MKX ECE2	3.02e-07	148	195	8	4d43efee96a6493abd78e9ca41aab73db0c80626
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH6 XIRP1 HK1 FEN1 AKAP6 AASDH MKX EVI5L	1.13e-06	176	195	8	4ed73c73972334f6dc4229920205547823252fa0
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC6A17 PGM2L1 UCHL1 PDIA2 AKAP6 GABBR2 ELAVL3 ECE2	1.70e-06	186	195	8	18fd311252299d6d30ddb32002ed069056108206
ToppCell	10x5'-Liver-Lymphocytic_NK-Cycling_NK\|Liver / Manually curated celltypes from each tissue	XIRP1 PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	1.84e-06	188	195	8	5eb94e652a734c6f15c68a178e9d05f0febcf34c
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ACADVL RCC2 UCHL1 NSD2 UBE2C PDCD11 SRRM2 ZNF292	2.16e-06	192	195	8	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PBK SSRP1 UCHL1 FEN1 DTYMK UBE2C MSH6 SNRPB	2.82e-06	199	195	8	8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIN9 BLK KCNMA1 DDX39B P2RY11 PJVK ELAVL3	4.30e-06	149	195	7	4b44108c40376a6b73258df40d2424e68f991383
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH8 COL19A1 LAMA4 GRM1	4.37e-06	97	195	6	f3c3fb260954f594a9ab8e1ac9a01115767cbc7a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH4 MYH8 COL19A1 LAMA4 GRM1 MKX ECE2	7.16e-06	161	195	7	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD NCAM2 COL6A5 KCNMA1 ACSL6 SIM2 RBPMS2	9.09e-06	167	195	7	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAD NCAM2 COL6A5 KCNMA1 ACSL6 SIM2 RBPMS2	9.09e-06	167	195	7	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH8 COL19A1 GRM1 MKX ECE2	1.02e-05	170	195	7	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FEN1 DYNC2I2 DTYMK UBE2C AMDHD2 TLDC2 EVI5L	1.23e-05	175	195	7	86dfce849b2ec023a72f7e887fa681b117155e51
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAIP ADGRV1 FMN1 AKAP6 SIM2 SLC25A12 SLC7A5	1.48e-05	180	195	7	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SLC6A17 KCNMA1 MYOM3 PELI2 THBS1 NINL	1.48e-05	180	195	7	d67d3196e6cc3dcd31023a4dc69310226181d583
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SLC6A17 KCNMA1 MYOM3 PELI2 THBS1 NINL	1.48e-05	180	195	7	573308d43425d9fba20787abdb7f8efefc48efb5
ToppCell	wk_15-18-Hematologic-Myeloid-APOE+_Mac2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NPL LILRB1 PLA1A KCNMA1 OAS2 CTSA CRYBB1	1.48e-05	180	195	7	c630a121aedd09a51ea18cc6e8552eb979e5b555
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 PBK FEN1 OSBPL5 PDIA2 UBE2C PJVK	1.53e-05	181	195	7	b203b616584cdbd0bbb0e382b2916d0bd49d3526
ToppCell	RV\|World / Chamber and Cluster_Paper	MARK3 DAPK2 FBN2 AKAP6 MYOM3 LAMA4 CSGALNACT1	1.53e-05	181	195	7	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 PBK FEN1 OSBPL5 PDIA2 UBE2C PJVK	1.53e-05	181	195	7	c748c16fd20d1949d33ff6290dc9d9016c4dc86c
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM2 PGM2L1 UCHL1 AKAP6 DPYSL3 GABBR2 ELAVL3	1.96e-05	188	195	7	bd091503f580dedab40e0996273101285d24b586
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 NCAM2 FREM1 MAGI2 AKAP6 FAT3 LAMA4	2.03e-05	189	195	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGM2L1 ADGRV1 ITGAV LAMA4 SIM2 NINL CSGALNACT1	2.03e-05	189	195	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGM2L1 ADGRV1 ITGAV LAMA4 SIM2 NINL CSGALNACT1	2.03e-05	189	195	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO10 COL6A5 FREM1 FAT3 LAMA4 MYOF THBS1	2.03e-05	189	195	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NPL NAIP FMN1 KCNMA1 AKAP6 WWP1 CSGALNACT1	2.10e-05	190	195	7	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH4 MYH6 CATSPERG	2.23e-05	77	195	5	7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 FREM1 MAGI2 FAT3 LAMA4 MYOF THBS1	2.24e-05	192	195	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	control-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	2.32e-05	193	195	7	ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	NSD3 SMCHD1 OAS2 LAP3 SLC7A5 SRRM2 ZNF292	2.32e-05	193	195	7	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 FREM1 MAGI2 FAT3 LAMA4 MYOF THBS1	2.40e-05	194	195	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 FREM1 MAGI2 FAT3 LAMA4 MYOF THBS1	2.40e-05	194	195	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYH6 DAPK2 AKAP6 COL19A1 MYOM3 ATP2A2 SNRPN	2.40e-05	194	195	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	NPL NAIP FMN1 KCNMA1 CTSA THBS1 SIPA1L1	2.40e-05	194	195	7	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 NCAM2 FREM1 MAGI2 FAT3 LAMA4 SNRPN	2.40e-05	194	195	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	NPL NAIP LILRB1 FMN1 KCNMA1 TPRG1 SIPA1L1	2.48e-05	195	195	7	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	NPL NAIP FMN1 KCNMA1 CTSA THBS1 SIPA1L1	2.48e-05	195	195	7	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PBK RUVBL2 DDX39B NPR1 DTYMK UBE2C SNRPB	2.48e-05	195	195	7	5556f280a5b42bda6e47b9d308946b7d5f4fa656
ToppCell	Influenza_Severe-T/NK_proliferative\|World / Disease group and Cell class	PBK FEN1 UGT3A2 DYNC2I2 DTYMK UBE2C DMC1	2.48e-05	195	195	7	6f079c2d7d08110a5e1822ea861b8037eb3f62c9
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM2 PGM2L1 UCHL1 PDIA2 AKAP6 GABBR2 ELAVL3	2.48e-05	195	195	7	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	Sepsis-Int-URO-Lymphocyte-B-Plasmablast\|Int-URO / Disease, condition lineage and cell class	EML6 PIK3C2B PRMT5 UBE2C EPN2 CRYBB1 SLC7A5	2.56e-05	196	195	7	e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8
ToppCell	Severe-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ACADVL SSR1 KCNK6 CALU NUCB1 LAP3 SLC35B1	2.56e-05	196	195	7	ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	SLC6A17 PGM2L1 UCHL1 KCNMA1 DPYSL3 GABBR2 ELAVL3	2.64e-05	197	195	7	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPL NAIP NRROS LILRB1 BTK CRYBB1 CD180	2.64e-05	197	195	7	759f26753f76af3ae8d8527c4d221206245a3d45
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO10 COL6A5 FREM1 TULP3 LAMA4 MYOF THBS1	2.64e-05	197	195	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast\|Influenza_Severe / Disease, condition lineage and cell class	THNSL1 PBK RAB3C UCHL1 UBE2C CRYBB1 LRP5	2.64e-05	197	195	7	9108edafbf5744ed65f556bcbbf819a9b71176a9
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	NSD3 SMCHD1 HNRNPA3 OAS2 LAP3 SRRM2 ZNF292	2.64e-05	197	195	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH1 KCNH8 SLC6A17 UCHL1 KCNMA1 ELAVL3 SNRPN	2.73e-05	198	195	7	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH1 KCNH8 SLC6A17 UCHL1 KCNMA1 ELAVL3 SNRPN	2.73e-05	198	195	7	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PBK CHAD BLK FEN1 UBE2C DMC1 CD180	2.73e-05	198	195	7	cfbe0bae21b6cd9cd15d3e659b618b44cfe3eaec
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	NSD3 SMCHD1 HNRNPA3 OAS2 LAP3 SRRM2 ZNF292	2.73e-05	198	195	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PBK NAF1 FEN1 NSD2 DTYMK LAP3 SLC7A5	2.73e-05	198	195	7	c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NSD3 SMCHD1 HNRNPA3 OAS2 LAP3 SRRM2 ZNF292	2.73e-05	198	195	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-B-Plasmablast\|Multiple_Sclerosis / Disease, condition lineage and cell class	PBK CHAD UCHL1 BTK UBE2C CRYBB1 SLC35B1	2.73e-05	198	195	7	c30b71b998acde080adb90a2016a165c5ed17a81
ToppCell	Sepsis-Bac-SEP-Lymphocyte-B-Plasmablast\|Bac-SEP / Disease, condition lineage and cell class	PBK UCHL1 FEN1 DYNC2I2 CALU UBE2C SLC35B1	2.73e-05	198	195	7	614055c11d1dd2f3f2b8783ec35a8f4570cad161
ToppCell	VE-cycling\|VE / Condition, Cell_class and T cell subcluster	PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	47c47ebc318a0b98841ca2656837bbd068899559
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	c0ea391bb347b99b94b5d7f02612ede938986745
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PBK UCHL1 FEN1 DTYMK UBE2C DMC1 SNRPB	2.82e-05	199	195	7	0cae9c80c15542fd86a82d7b6d6a3ad690cee410
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	96af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PBK SSRP1 FEN1 DTYMK UBE2C HNRNPA3 SNRPB	2.82e-05	199	195	7	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	VE-cycling-\|VE / Condition, Cell_class and T cell subcluster	PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	c0a67149a19b65b3069dbc5261d81f658e6e39a2
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	6df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	PBK FEN1 DYNC2I2 DTYMK UBE2C DMC1 MSH6	2.82e-05	199	195	7	e3b69608c834bd8ce6bedde298a2763cc0d7d573
ToppCell	Mild-T/NK_proliferative\|Mild / Disease group and Cell class	PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	64a5c91243ee999ea21ffddd450d3e5fdbf6470b
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PBK RUVBL2 DYNC2I2 CALU DTYMK UBE2C SNRPB	2.82e-05	199	195	7	89d7622c4ae146900d963ac68c6bf011e8674665
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	4394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCell	COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Mild / Disease group, lineage and cell class	PBK FEN1 DYNC2I2 NSD2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCell	18-Airway-Mesenchymal-Cartilage\|Airway / Age, Tissue, Lineage and Cell class	MATN1 CHAD GFAP CALU SIM2 THBS1 CSGALNACT1	2.82e-05	199	195	7	f5d0aa4170367c080d3c2f01d9af3529762917fa
ToppCell	wk_08-11-Hematologic\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPL NAIP NRROS LILRB1 BTK CRYBB1 CD180	2.82e-05	199	195	7	edc9afd7be8543cb93a2bb874a14aad0417dfa92
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease group, lineage and cell class	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCell	wk_08-11-Hematologic-Myeloid-SPP1+_Mac\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPL NAIP NRROS BTK WWP1 CRYBB1 CD180	2.82e-05	199	195	7	d94cf750599366061066074e8007d707adf6fc5a
ToppCell	(5)_Plasmablast\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PBK SSR1 FEN1 CALU DTYMK UBE2C SLC35B1	2.82e-05	199	195	7	f7d2ce4066436bbfe78150b579d22371a93ba76d
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	5b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.82e-05	199	195	7	cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCell	Non-neuronal-Dividing\|World / Primary Cells by Cluster	MIS18BP1 MYO10 PBK FEN1 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	50fa7b34a05f2c5ebbc7d113bd8e31326688a231
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	c865efaaaecccbf9c833d6c1cbe85809a3ec306d
ToppCell	severe-T/NK_proliferative\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PBK FEN1 DYNC2I2 DTYMK UBE2C DMC1 MSH6	2.91e-05	200	195	7	9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PBK FEN1 DYNC2I2 DTYMK UBE2C DMC1 MSH6	2.91e-05	200	195	7	97e47eb69d1d4cab45256acca9589837eb7817e7
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	c88d8e67647c90d1fa2569516865a9fd766eaf1c
ToppCell	(5)_Epithelial_cells-(5)_Epi_dividing\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	b46b2064362efc64edf19ab2b21bc89047c9d943
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells\|5w / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	2ee167b8bddd11fd5b1f61f87fcdf757aee3193e
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	d92d3bc63a56a604d7b1d49e62d4304e5e4017f2
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 MYO10 FEN1 DYNC2I2 DHX40 UBE2C SNRPB	2.91e-05	200	195	7	9e1b62a703fb7d413ce580448a1df5127c28e8a7
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PBK FEN1 DYNC2I2 DTYMK UBE2C DMC1 MSH6	2.91e-05	200	195	7	5d11a2c0021805e78d97dc1638bf73ca1faede66
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	MIS18BP1 MYO10 PBK ADGRV1 FEN1 HNRNPA3 SNRPB	2.91e-05	200	195	7	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease, condition lineage and cell class	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.91e-05	200	195	7	00538c4cbab5da00b3a366717d38a3ba5cfe3f65
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	28935053cd6918cd2e9f3e7691f8522216585cb6
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	c784459a62bebec560e79aba83de8611457437bc
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative\|Influenza_Severe / Disease, condition lineage and cell class	PBK LIN9 FEN1 DYNC2I2 DTYMK UBE2C DMC1	2.91e-05	200	195	7	e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7
ToppCell	severe-cDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NRROS RCC2 PLA1A BTK KCNK6 LAP3 MYOF	2.91e-05	200	195	7	26e04ea276dbca5cde48335c401269c7123b54d2
ToppCell	(5)_Epi_dividing\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	PBK SSRP1 FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	948c55aa1c25f8a69b1bd3ef53fd32aa222f592c
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating-Cycling\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 PBK FEN1 DYNC2I2 DTYMK UBE2C SNRPB	2.91e-05	200	195	7	322337a5a9cc2de1913ee9258c98ae51fb4bd6bb
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	MIS18BP1 MYO10 FEN1 DYNC2I2 DHX40 UBE2C SNRPB	2.91e-05	200	195	7	c00cc0b91baa37828895d9d6b8acbc6aa503215a
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	MIS18BP1 MYO10 PBK ADGRV1 FEN1 HNRNPA3 SNRPB	2.91e-05	200	195	7	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	2.38e-07	51	193	7	CID000122274
Drug	purealin	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	5.88e-07	58	193	7	CID006419303
Drug	AC1N9ZZC	MYH1 MYH2 MYH4 MYH6 MYH8 KCNH8 NCAM2 DDX52 CBL MMUT	5.97e-07	149	193	10	CID004369374
Drug	fast white	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6	1.40e-06	42	193	6	CID000024008
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10 ATP2A2	2.20e-06	100	193	8	CID000060765
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	TM7SF3 MED12 DNAH3 CAMKK2 FARS2 SIPA1L1 TAF15 QSER1 SRRM2 TJP3	6.77e-06	195	193	10	1704_DN
Drug	2bq7	NPL MYH1 MYH2 MYH4 MYH6 MYH8 AMDHD2 TAF15	1.03e-05	123	193	8	CID006540267
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 MYH6 MYH8 HK1 MYL6 MYO10 SSR1 FEN1 KCNMA1 NPR1	1.19e-05	304	193	12	CID000004795
Drug	AC1NRBPQ	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 FEN1 SF3B3	2.27e-05	137	193	8	CID005288569
Drug	2,3-bis(3'-hydroxybenzyl)butyrolactone	MIS18BP1 PBK L2HGDH PGM2L1 SSRP1 FEN1 ACAA2 DDX39B DYNC2I2 NSD2 CALU BSDC1 SALL4 MSH6 THBS1 SF3B3 NINL SLC7A5 QSER1 EXOC2 SNRPB ZNF292	2.35e-05	961	193	22	ctd:C029497
Drug	K-Cl	NPL MYH1 MYH2 MYH4 MYH6 MYH8 KCNH8 MYL6 MYO10 MARK3 KCNMA1 NPR1 AASDH GABBR2 MARK4 ATP2A2	2.86e-05	567	193	16	CID000004873
Drug	clenbuterol	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10 PDIA2	2.94e-05	142	193	8	CID000002783
Drug	3-(1H-pyrrole-2-carboxylate	MYH6 XIRP1 FKBP9 RCC2 KCNMA1 HSPA4 AKAP6 GRM1 CAMKK2 ATP2A2	3.17e-05	233	193	10	CID000005114
Drug	3alpha, 7alpha-dihydroxy-5beta-cholestanoyl-CoA	ACADVL ACAA2 ACAD9	3.25e-05	8	193	3	CID000440420
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	MATN1 ALDH1L1 NSD2 OAS2 SIM2 MYOF CAMKK2 SIPA1L1 MARK4	3.39e-05	188	193	9	5490_UP
Drug	aspartate	NPL HK1 FKBP9 ALDH1L1 GFAP PIK3C2B HSPA9 FOLH1 DHX40 AMDHD2 SIM2 GRM1 LAP3 MSH6 SLC25A12	3.82e-05	518	193	15	CID000000424
Drug	NSC226080	MYH1 MYH2 MYH4 MYH6 MYH8 NAIP FKBP9 ANKHD1 RUVBL2 LILRB1 FBN2 PIK3C2B HSPA4 CBL PPP2R1A THBS1 CCNB3 PITPNM3 SLC7A5	3.96e-05	782	193	19	CID000005040
Drug	(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	NR2C1 NSD3 DMC1 MYOF PPP2R1A SLC25A12 SIPA1L1 QSER1 MMUT	4.16e-05	193	193	9	982_UP
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	NR2C1 SLC22A14 UCHL1 KCNMA1 LAMA4 SIM2 GRM1 SIPA1L1 ELAVL3	4.69e-05	196	193	9	4361_UP
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	INPP5B NSD3 KCNMA1 DPYSL3 AMDHD2 OAS2 CBL THBS1 MUC2	4.69e-05	196	193	9	7310_UP
Drug	Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	NR2C1 MYH4 DAPK2 ALDH1L1 COL19A1 GABBR2 MYOF THBS1 MARK4	4.88e-05	197	193	9	2618_UP
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A	MARK3 SSR1 PIK3C2B TRAPPC11 CALU PELI2 MSH6 FARS2 UBE3C	5.08e-05	198	193	9	1579_DN
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; HL60; HG-U133A	MYO10 PIK3C2B ACAA2 CALU CBL MYOF SLC25A12 FARS2 ZNF350	5.28e-05	199	193	9	1733_DN
Drug	hexadec-11-enal	LIN9 BTK HSPA4 LAP3 BOLL	5.29e-05	48	193	5	CID000062073
Drug	Harpagoside [19210-12-9]; Up 200; 8uM; HL60; HT_HG-U133A	CETN1 DPYSL3 LAMA4 OAS2 GABBR2 DMC1 THBS1 LRP5 ELAVL3	5.49e-05	200	193	9	2935_UP
Drug	4-chloroaniline	MYH1 MYH2 MYH4 MYH6 MYH8 MYO10 FBN2 ALOX15 FOLH1	5.93e-05	202	193	9	CID000007812
Drug	blebbistatin	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	6.03e-05	116	193	7	CID003476986
Drug	B0683	MYH1 MYH2 MYH4 MYH6 MYH8 MYL6 MYO10	6.37e-05	117	193	7	CID006398969
Drug	UTP-NA	HK1 PGM2L1 SSRP1 ZNF77 FEN1 KCNMA1 NPR1 DTYMK MSH6 CAMKK2 P2RY11 ENTPD5 ATP2A2	6.50e-05	420	193	13	CID000001181
Drug	Phleomycin E	KCNMA1 NUCB1	7.15e-05	2	193	2	CID000159334
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8 FBN2	3.24e-10	15	191	6	DOID:0050646 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	2.65e-09	10	191	5	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	8.23e-09	12	191	5	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	8.23e-09	12	191	5	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	1.33e-08	13	191	5	DOID:397 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	NPL MYH1 MYH2 MYH4 MYH6 MYH8 HNRNPA3	2.51e-08	48	191	7	DOID:423 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CD109 ALDH1L1 FBN2 FEN1 UGT3A2 AKAP6 DNAH3 FOLH1 WNT8B AMDHD2 GRM1 MSH6 CCNB3 BOLL ZNF292	5.74e-05	702	191	15	C0009402
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	9.93e-05	71	191	5	DOID:0050700 (implicated_via_orthology)
Disease	Sotos syndrome 1 (implicated_via_orthology)	NSD3 NSD2	1.25e-04	3	191	2	DOID:0112103 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH8	1.75e-04	80	191	5	DOID:12930 (implicated_via_orthology)
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK3 MARK4	2.48e-04	4	191	2	DOID:0070356 (implicated_via_orthology)
Disease	Abnormal muscle tone	HK1 ZNF292	6.15e-04	6	191	2	C0852413
Disease	hair colour measurement	MARK3 L2HGDH ADGRV1 DCT TPRG1 FOLH1 NINL LRP5 SLC7A5 QSER1 EXOC2 CSGALNACT1	7.13e-04	615	191	12	EFO_0007822
Disease	squamous cell carcinoma	MARK3 SLC6A17 RCC2 TPRG1	9.48e-04	67	191	4	EFO_0000707
Disease	retinal disease (biomarker_via_orthology)	GFAP UCHL1	1.14e-03	8	191	2	DOID:5679 (biomarker_via_orthology)
Disease	Heart Failure, Diastolic	MYH6 ALOX15 SIPA1L1	1.26e-03	33	191	3	C1135196
Disease	lifestyle measurement, systolic blood pressure	DAPK2 FOLH1	1.46e-03	9	191	2	EFO_0006335, EFO_0010724
Disease	refractive error, age at onset, Myopia	SSR1 BMP3 SUMF1 KCNMA1 AKAP6 SLC25A12	1.66e-03	193	191	6	EFO_0004847, HP_0000545, MONDO_0004892
Disease	Kunitz-type protease inhibitor 2 measurement	KCNK6 CATSPERG	1.81e-03	10	191	2	EFO_0008200
Disease	tauopathy (implicated_via_orthology)	SNRPB SNRPN	1.81e-03	10	191	2	DOID:680 (implicated_via_orthology)
Disease	Schizophrenia	HK1 CETN1 LILRB1 GFAP MAGI2 MED12 HSPA9 ACSL6 FOLH1 HNRNPA3 GRM1 THBS1 CAMKK2 ATP2A2	1.92e-03	883	191	14	C0036341
Disease	Epilepsy, Cryptogenic	L2HGDH GFAP GRM1 STAMBP	2.01e-03	82	191	4	C0086237
Disease	Awakening Epilepsy	L2HGDH GFAP GRM1 STAMBP	2.01e-03	82	191	4	C0751111
Disease	Aura	L2HGDH GFAP GRM1 STAMBP	2.01e-03	82	191	4	C0236018
Disease	osteosarcoma (is_marker_for)	CBL MSH6	2.21e-03	11	191	2	DOID:3347 (is_marker_for)
Disease	polychlorinated biphenyls measurement, gestational serum measurement	FMN1 SUMF1	2.64e-03	12	191	2	EFO_0007042, EFO_0007964
Disease	age at onset, Myopia	BMP3 KCNMA1 AKAP6 SLC25A12 HYDIN	2.99e-03	150	191	5	EFO_0004847, HP_0000545
Disease	human Chorionic Gonadotropin measurement	RUVBL2 NUCB1	3.10e-03	13	191	2	EFO_0008156
Disease	ximenoylcarnitine (C26:1) measurement	WWP1 LRP5	3.10e-03	13	191	2	EFO_0800543
Disease	Muscular Dystrophy, Facioscapulohumeral	HSPA4 SMCHD1	3.10e-03	13	191	2	C0238288
Disease	homocysteine measurement	ALDH1L1 GABBR2 MMUT	3.30e-03	46	191	3	EFO_0004578
Disease	Myopia	OR2G6 SSR1 LILRB1 BMP3 KCNMA1 AKAP6 SLC25A12 UBE3C	3.75e-03	385	191	8	HP_0000545
Disease	hearing impairment	ADGRV1 SALL4 LOXHD1 PJVK	3.83e-03	98	191	4	C1384666
Disease	cortex volume change measurement	MAGI2 SUMF1	4.14e-03	15	191	2	EFO_0021500
Disease	circadian rhythm	NPL BLK PDIA2 STK31 BOLL	4.26e-03	163	191	5	EFO_0004354
Disease	Malignant neoplasm of breast	MYH1 XIRP1 CD109 BTK MED12 AKAP6 COL19A1 NSD2 UBE2C ARFGEF2 APCS HELQ MSH6 THBS1 SIPA1L1	4.41e-03	1074	191	15	C0006142
Disease	heart disease (biomarker_via_orthology)	THBS1 ATP2A2	5.32e-03	17	191	2	DOID:114 (biomarker_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	SRRM2 ZNF292	5.32e-03	17	191	2	DOID:0060307 (is_implicated_in)
Disease	Epilepsy	L2HGDH GFAP GRM1 STAMBP	5.58e-03	109	191	4	C0014544
Disease	syndrome (implicated_via_orthology)	NSD3 NSD2	5.96e-03	18	191	2	DOID:225 (implicated_via_orthology)
Disease	Mental Depression	GFAP MED12 FOLH1 OAS2 GRM1 ATP2A2	6.38e-03	254	191	6	C0011570

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSEAGFVFTGKQDTV	NAIP	181	Q13075
AGQLGVEFFDEKLNS	PPP2R1A	431	P30153
NEFKRVGESGVSDSF	CATSPERG	51	Q6ZRH7
EFFKGQDSLGQEVLF	EVI5L	166	Q96CN4
DFDSSEVLQGLDFFG	DDX52	36	Q9Y2R4
ENEEFLIGFNITSKG	BMP3	211	P12645
FDAGFIEDLTHKTGN	CCDC61	46	Q9Y6R9
SDFINIGGFDLDIKG	CSGALNACT1	431	Q8TDX6
KGLSDFLGVISDTFA	BSDC1	76	Q9NW68
DLTFLKELGTGQFGV	BTK	401	Q06187
ESVGGKILFATDDFF	ALLC	6	Q8N6M5
FGTKGLAITFVSDEN	DDX39B	381	Q13838
FVGGIDFKTNESDLR	BOLL	36	Q8N9W6
VDDFFQGTKAALAGG	DPYSL3	86	Q14195
SSISFEILGFNSKGE	GTPBP2	221	Q9BX10
NGGLANIFTVFAKTE	ACAD9	216	Q9H845
QEFDDLIFALKTGAG	ADGRV1	6256	Q8WXG9
TQVGDFLGDSARFNK	ARFGEF2	691	Q9Y6D5
ISLFEGANFKGNTIE	CRYBB1	151	P53674
IFSAAGAAFTKLGEL	BAP18	11	Q8IXM2
TQDEFKSLFGSIGDI	ELAVL3	51	Q14576
AFLGAEEAKTFDQLT	CALU	51	O43852
TGDFVTVKDGEIFFL	AASDH	426	Q4L235
LSSETKAVLEEFGGF	NPR1	1016	P16066
LEKFSDGAFLGVTTL	CHAD	256	O15335
ITEAFGEFRTGKTQL	DMC1	121	Q14565
VKGIELGAFDSTIFQ	CD180	211	Q99467
SVGKSGTINEAFLFE	CCNB3	996	Q8WWL7
GFVIFDSRAGAEAAK	RBPMS2	71	Q6ZRY4
ALTETGSVFAFGENK	RCC2	216	Q9P258
LGEGVSTDQVGEFFK	TAF15	241	Q92804
NATITEELFFKGLIG	NR2C1	561	P13056
LGEQLGFEFFETSAK	RAB3C	161	Q96E17
DQFAKGQDTVAIEGF	QSER1	1326	Q2KHR3
LLKGFTGSVADLAFA	EDC4	171	Q6P2E9
GSFETAFKDTGLGRE	FMN1	251	Q68DA7
TDAGKAFSIAFALLG	KCNK6	116	Q9Y257
FAINFKVGSSGDIAL	LGALS4	221	P56470
QFTSAGENFDKLLAG	LAP3	51	P28838
LAAADDKLSGFQGDF	P2RY11	16	Q96G91
ELVVDAIFGFSFKGD	NAXE	181	Q8NCW5
LLKDGFGFADSTVLQ	ENTPD5	386	O75356
CLAEGGDLNSFEFKS	LIN9	476	Q5TKA1
GLAIQFAITKAFGDA	MATN1	121	P21941
FNTDLGENSGIGKLF	MIS18BP1	1096	Q6P0N0
KENEGFGFVIISSLN	MAGI2	926	Q86UL8
AFDTTLGGRKFDEVL	HSPA4	226	P34932
EGTLGFFIASDAKEV	KCNMA1	656	Q12791
FQEAGGSVLTNFEVK	L2HGDH	206	Q9H9P8
LKSLGADFTFGFIQV	MMS19	166	Q96T76
LFSNLNGTIKDDFSE	EPN2	446	O95208
FGGTVTGLDFFKLEE	KIAA1109	1136	Q2LD37
RISKLGSGNDFEVFF	FOLH1	511	Q04609
GLEDAAAVDFQFSKG	LRP5	61	O75197
KNAGTDANVFITLFG	LOXHD1	981	Q8IVV2
FAAASGKGDVQLFDL	DYNC2I2	451	Q96EX3
DDALGFALGSLFVKA	ECE2	481	P0DPD6
GVLDIAGFEIFDFNS	MYH8	461	P13535
EFKEAFQLFDRTGDG	MYL6	11	P60660
KGGLSTFFEAQDALS	EXOC2	206	Q96KP1
FNKLSGAVLFEDGGA	MKX	6	Q8IYA7
FNGLEGDDFKTASGL	MUC2	531	Q02817
GVLDIAGFEIFDFNS	MYH2	461	Q9UKX2
GKEVLFAFEESIGFL	PGM2L1	426	Q6PCE3
LSSGVDVDKGFAIAF	CTXND2	6	A0A1B0GV90
SRLGFNEFSLSKEDG	KIR3DL3	51	Q8N743
IFEKSLVAFEGEGQF	NSD2	276	O96028
GFEKSNIGISIDSFQ	FREM1	1081	Q5H8C1
DFKSIGILDIFGFEN	MYO10	426	Q9HD67
FSFEGTKLDVGNIVL	SLC7A5	231	Q01650
GTLFEADFSLLDGIK	ALOX15	271	P16050
AVFVLGDAELKGSGF	MED12	1226	Q93074
EEGTFSGSAKLVFLD	LRRC38	96	Q5VT99
GVLDIAGFEIFDFNS	MYH1	461	P12882
TRDLETFSKFLDNGG	PDIA2	481	Q13087
DFSLAGALNAGFKET	GFAP	51	P14136
LSADDIAGKFQFSRG	POGK	181	Q9P215
VDTSLGKFFIGQFSD	MSH6	561	P52701
EFLASTQRKEFGDTG	NUCB1	316	Q02818
GNSDGTLVLFFSDLK	OAS2	71	P29728
EKGDFIALDLGGSSF	HK1	76	P19367
VFEVKSTNGDTFLGG	HSPA9	261	P38646
AVTIFFGANDSALKD	IAH1	81	Q2TAA2
TGLEEVKQFFALNGS	PIK3C2B	1021	O00750
GDSGEQIAGFVKEFS	CTSA	431	P10619
DRDSTFNVFVGKGQL	FKBP9	76	O95302
LGFALGSLFVKATFD	EEF1AKMT4-ECE2	556	P0DPD8
FEELEFLSKINGGLT	ANP32C	41	O43423
FGQDEDVTSKAFTGR	ATP2A2	641	P16615
VSVLEAEGVFEKGSF	CD109	71	Q6YHK3
TQGRLDDFFKVTGSL	FEN1	336	P39748
ESGGLFVEDENKFIF	HYDIN	3356	Q4G0P3
FKDNFSSAIAGVVEG	BBS2	281	Q9BXC9
GKIVDDNIRSLFFGD	DNAH3	2351	Q8TD57
KLEVSGFDLGDSFSL	COL19A1	51	Q14993
VSGGELFDFLAQKES	DAPK2	106	Q9UIK4
GSFLIRESETNKGAF	BLK	146	P51451
GKEERVSFGQNFDAL	COL6A5	591	A8TX70
QGGFSIDFTKADRVL	ITGAV	186	P06756
NFDSAFDAEKGVGTI	FAT3	1401	Q8TDW7
FGNLAELESSKEQFA	RAP1GDS1	206	P52306
IKDIQFSESGEGTRF	IDI2-AS1	61	Q9NZ38
IADTLGAVAKQGFDF	PRMT5	26	O14744
DFGFSNEFTVGGKLD	MARK3	196	P27448
KIADFGFSNEFTLGS	MARK4	196	Q96L34
LFGLDGSFVSEKTFE	GABBR2	536	O75899
QVAAKTVFEGFTEGE	INPP5B	561	P32019
FGVSNEFKGSDALLS	CAMKK2	331	Q96RR4
SGLFQGDTFRITKAD	CBL	171	P22681
SVLVSGDDFGLVKLF	EML6	531	Q6ZMW3
SLLATGDDFGFVKLF	EML6	1206	Q6ZMW3
NIVTGDDFGLVKLFD	EML6	1896	Q6ZMW3
KLGFADLNLAEFAGS	FAM102B	96	Q5T8I3
EKISGLSSFGIELGF	HELQ	396	Q8TDG4
GFTFDIHTGKAVDID	FBN2	1796	P35556
FSGFGDLEKIEISQN	FSHR	66	P23945
FLEEISFGGSVQLTK	C4orf36	46	Q96KX1
GDDLVTSLFAAKFGQ	DZANK1	721	Q9NVP4
TSLFAAKFGQGLEDQ	DZANK1	726	Q9NVP4
LDFLIKSSFIGVSGE	GRM1	451	Q13255
RELAAKAGGFNDFAT	DHX40	541	Q8IX18
KFANLLDAVGEFGTF	SLC22A14	51	Q9Y267
LFAEFQDKVAAGNGI	SALL4	441	Q9UJQ4
EEKVEIILNAGFFGF	CFAP47	2911	Q6ZTR5
ASDLTDAFVEVKFGN	C2CD5	21	Q86YS7
FLATGGEAAFELETL	NRROS	241	Q86YC3
ASIQKISFFDGFEGG	LAMA4	1246	Q16363
DVFIKEEGSGSSALF	OSBPL5	606	Q9H0X9
NSSEKGFLLLGFSDQ	OR2G6	6	Q5TZ20
GLKFSDTDLLDFGQC	NPL	171	Q9BXD5
GFLALFSGDTGEIKS	RUVBL2	256	Q9Y230
DKDASFLAGGLFTDF	SMCHD1	1376	A6NHR9
GFTNKGTEDFIVESL	SSR1	106	P43307
GFSSEVKEDLNGPFL	SRRM2	1346	Q9UQ35
KVLRFLNVAFDGTGD	TBC1D31	41	Q96DN5
LQDGRIFIGTFKAFD	SNRPN	21	P63162
GELANTLTSKFEFLG	FNBP4	531	Q8N3X1
ENGEFLSLDLGGSKF	HKDC1	76	Q2TB90
DSQVAFDGFSLCKEG	LILRB1	146	Q8NHL6
FAAGFDSSKNIFLGE	PELI2	156	Q9HAT8
ADLTRVETFGFQGKA	PMS2P2	161	O95744
SIDKQGTSGESFFDL	SIPA1L1	211	O43166
QTLDGFVFVVASDGK	SIM2	86	Q14190
LQDGRIFIGTFKAFD	SNRPB	21	P14678
GVLDIAGFEIFDFNS	MYH4	461	Q9Y623
AFDVLGFTSEEKAGV	MYH6	336	P13533
FKEGFVAVLSSNAGV	NINL	66	Q9Y2I6
GEGAKQETFTFALTL	SLC35B1	41	P78383
LTEAEKFGDSFVFEG	SUMF1	146	Q8NBK3
TVKFGGQLLSFDIGD	SSRP1	111	Q08945
GIKASNTAEVFFDGV	ACADVL	301	P49748
DLFGLGIFKNGSDSL	AKAP6	1576	Q13023
EFGLASGVFTRDINK	ALDH1L1	831	O75891
GNVVADFSGFLKVTE	ACSL6	291	Q9UKU0
GFSEVADFLIKAGAD	ANKHD1	516	Q8IWZ3
VDREGTGKISFNDFL	CETN1	76	Q12798
LATATFAGIENKFGL	SLC25A12	641	O75746
GKLFVGGLSFDTNEQ	CIRBP	6	Q14011
GGLLKDFTATDLSEF	ACAA2	21	P42765
EQGIVGDFDFTKSVS	STK31	866	Q9BXU1
ADFQSANLFEGTDLK	PLA1A	36	Q53H76
DTFRFDSEKLQVGQG	PDCD11	961	Q14690
VGFGEAISKQFVDAL	WNT8B	136	Q93098
FDIFELTGAARKGSG	THBS1	31	P07996
FGNGISNDEEIVKFT	ZNF77	61	Q15935
FGDLFDEAIKLGLTA	TRAPPC11	326	Q7Z392
RAVDGFTFTEGDKSL	NCAM2	336	O15394
KGGFEREETATFALL	PJVK	231	Q0ZLH3
GKFDRSQSFVGEIGD	APCS	161	P02743
FQETGFFKLTDHGLE	STAMBP	371	O95630
SFEGFQAVSLKQEGD	TPRG1	6	Q6ZUI0
FFLIKVINSETEGAG	ZNF292	331	O60281
FLEEEGKAVLNFSAS	THNSL1	111	Q8IYQ7
SAGLEAIQLDGEIFF	TBC1D10B	481	Q4KMP7
KLFIGGLSFETTDDS	HNRNPA3	36	P51991
NGVITDKADIFAFGL	PBK	221	Q96KB5
SFRNALEGFDKADGT	DCT	346	P40126
VLKTGFLFVASEFGN	SF3B3	341	Q15393
VFALQNATGDGKFID	NSD3	506	Q9BZ95
EFLKSSDGIGFSGQV	PITPNM3	246	Q9BZ71
IKNSVEFTGNGDSFL	ZNF350	151	Q9GZX5
RDSEEFGVKLGSQIF	TJP3	201	O95049
RANKFGVASGEEDFT	ZBED6	186	P86452
LDKSVQGTGLAFIAF	SLC6A17	431	Q9H1V8
TGSNSFFVKGDLDSL	TLDC2	151	A0PJX2
GLFGDLAFAAKESLV	WDR24	346	Q96S15
KSFDFFLEETLGGRG	UGT3A2	91	Q3SY77
QDLENFIAKFGDSGF	UGT3A2	281	Q3SY77
SRGVQEQTKAFLDGF	WWP1	766	Q9H0M0
FAGIKDGESLQLFEQ	FARS2	206	O95363
ISLDFEGTENFKGHT	UHRF1BP1	701	Q6BDS2
GDVQATSRKFEEGSF	XIRP1	121	Q702N8
QAFGIGLSSFDSKLA	TULP3	426	O75386
NVLDGLEEKGRFSSF	TRAV1-2	66	A0A0B4J238
GFFLSKLLGTSADVD	UBE3C	841	Q15386
GDKGISAFPESDNLF	UBE2C	46	O00762
LGFEDGSVLKQFLSE	UCHL1	106	P09936
GNSSEGLIEFSVGKF	TM7SF3	26	Q9NS93
GFGNVSANTDAEKIF	KCNH8	436	Q96L42
SGVAFTGAKENFSLD	DTYMK	101	P23919
LETLKFNGTDFGVGE	NAF1	11	Q96HR8
KGTLDFGADADFVVL	AMDHD2	371	Q9Y303
AKVIATGFADLGFDV	MMUT	631	P22033
AFSQTVKEIFGGNAD	MYOF	376	Q9NZM1
FDLGNKITISTDAFE	MYOM3	481	Q5VTT5